Characteristics and outcomes of patients with pregnancy-associated colorectal cancer.
1/5 보강
[INTRODUCTION] Pregnancy-associated colorectal cancer (PACRC) is a rare condition with limited existing research.
- p-value P = .02
- 95% CI 0.16-0.84
- HR 0.36
APA
Wang G, Zhang Z, et al. (2025). Characteristics and outcomes of patients with pregnancy-associated colorectal cancer.. The oncologist, 30(11). https://doi.org/10.1093/oncolo/oyaf377
MLA
Wang G, et al.. "Characteristics and outcomes of patients with pregnancy-associated colorectal cancer.." The oncologist, vol. 30, no. 11, 2025.
PMID
41237054 ↗
Abstract 한글 요약
[INTRODUCTION] Pregnancy-associated colorectal cancer (PACRC) is a rare condition with limited existing research. Its occurrence during pregnancy introduces unique physiological complexities, making diagnosis and treatment particularly challenging for clinicians. This study aimed to characterize PACRC by examining its clinical features, obstetric management approaches, therapeutic strategies, and maternal-fetal survival outcomes.
[METHODS] A comprehensive literature review was conducted using studies published from January 2016 to March 2024. Cox proportional hazards regression was used to identify prognostic factors affecting overall survival (OS). Chi-square tests were used to assess differences in fetal mortality and preterm birth rates across exposure groups.
[RESULTS] A total of 121 PACRC patients were included, and most were diagnosed in late pregnancy or postpartum. PACRC was more frequently located in the left colon and rectum, typically diagnosed at advanced stages. Most tumors were moderately or poorly differentiated adenocarcinomas. The 1-year and 2-year maternal survival rates were 69.90% and 58.60%, respectively. Prognosis was more favorable when the tumor is in the rectum rather than the colon. Surgical intervention and chemotherapy, particularly when initiated during pregnancy, were associated with significantly improved outcomes compared to postpartum therapy (HR = 0.36; 95% CI: 0.16-0.84; P = .02). Fetal mortality was not directly associated with prenatal diagnostic or therapeutic procedures, although iatrogenic pregnancy termination may contribute to fetal risk.
[CONCLUSIONS] PACRC, characterized by its subtle presentation, requires vigilant clinical monitoring and prompt intervention, with consideration of gestational age, histological type, and tumor stage. Our findings suggest that early surgical intervention and chemotherapy during pregnancy may offer greater survival benefits than treatment initiated only after pregnancy termination.
[METHODS] A comprehensive literature review was conducted using studies published from January 2016 to March 2024. Cox proportional hazards regression was used to identify prognostic factors affecting overall survival (OS). Chi-square tests were used to assess differences in fetal mortality and preterm birth rates across exposure groups.
[RESULTS] A total of 121 PACRC patients were included, and most were diagnosed in late pregnancy or postpartum. PACRC was more frequently located in the left colon and rectum, typically diagnosed at advanced stages. Most tumors were moderately or poorly differentiated adenocarcinomas. The 1-year and 2-year maternal survival rates were 69.90% and 58.60%, respectively. Prognosis was more favorable when the tumor is in the rectum rather than the colon. Surgical intervention and chemotherapy, particularly when initiated during pregnancy, were associated with significantly improved outcomes compared to postpartum therapy (HR = 0.36; 95% CI: 0.16-0.84; P = .02). Fetal mortality was not directly associated with prenatal diagnostic or therapeutic procedures, although iatrogenic pregnancy termination may contribute to fetal risk.
[CONCLUSIONS] PACRC, characterized by its subtle presentation, requires vigilant clinical monitoring and prompt intervention, with consideration of gestational age, histological type, and tumor stage. Our findings suggest that early surgical intervention and chemotherapy during pregnancy may offer greater survival benefits than treatment initiated only after pregnancy termination.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Combined sleep intervention and nutritional support to enhance postoperative recovery in gastric cancer: a prospective randomized controlled trial.
- RagC senses β-hydroxybutyrate abundancy to suppress mTORC1 and tumor growth.
- Development of a prognostic model for thyroid cancer based on mitochondrial metabolism-related genes and immune profiling.
- Author Correction: Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.
- ASO Visual Abstract: Synergistic Effects of Psychological Resilience Training and Nutritional Support on Postoperative Recovery, Nutritional Reconstitution, Sleep Quality, and Long-term Survival in Gastric Cancer-A Randomized Controlled Trial.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.